Two years ago there was a great deal of press about the use of the Estimated Average Glucose (eAG) and how this would revolutionize diabetes care, making things easier for our patients to understand their diabetes. However in practice there has not been a big shift in that direction. Now …
Read More »Monthly Archives: July 2012
Exercise and Sport in Diabetes, 2nd Ed: Guidelines for Carbohydrate Intake Before Exercise
Diet and Nutritional Strategies During Sport and Exercise in Type 1 Diabetes Elaine Hibbert-Jones and Gill Regan What should the target level of blood glucose be before exercise?
Read More »Use of the Estimated Average Glucose (eAG) in Patient Care, Part 1 of 2
In this week’s Homerun Slides, we examine the use of eAG which is not always just confusing to patients.
Read More »ORIGIN Trial and Steve Freed Question, AACE 2012
Silva A. Arslanian, MD: Difficulties of Educating Parents
Silva A. Arslanian, MD, talks about the particular challenges of type 2 diabetes in adolescence and the role parents should but often do not play in helping to manage their children’s diabetes….
Read More »Silva A. Arslanian, MD, Q4: Disparities in diabetes rates between children of different socio-economic class
Dr. Arslanian confirms that she is seeing a higher incidence of type 2 diabetes in children in lower socio-economic classes, where there is also a higher obesity rate. More videos with Dr. Arslanian: Silva A. Arslanian, MD, Introduction T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to …
Read More »Silva A. Arslanian, MD: How does the drug approval process differ for children?
Silva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….
Read More »Silva A. Arslanian, MD: What drugs can be prescribed to children with diabetes?
With all of the discussion in the medical community and beyond regarding new drug approvals for diabetes, it is easy to forget that many of these drugs are not approved for children and adolescents. Silva A. Arslanian, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, explains why this is and describes …
Read More »Silva A. Arslanian, MD, Q1: T2DM in Children – Earlier co-morbidities?
Dr. Arslanian talks about the earlier incidence rate of ESRD of people who have type 2 in childhood as well as her own team’s studies on cardiovascular markers, and the premature “aging” of the CV system seen in these individuals. She also discusses the challenges of children growing up in …
Read More »Silva A. Arslanian, MD, Introduction
Dr. Arslanian introduces herself and describes her recent research and the “sobering reality” of researching type 2 in children and adolescents. More videos with Dr. Arslanian: T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to children with diabetes? How does the drug approval process differ for children? …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.